Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about Oncogenic 8 relevant journals, 160 Conference Proceedings, 5 workshops are presently dedicated exclusively to oncogenic and about 2,070 articles are being published on oncogenic.
Oncogenic is causing the formation of a tumor. An oncogene is a gene that has the potential to cause cancer. The proto-oncogene can become an oncogene by a relatively small modification of its original function There are three basic methods of activation.OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
A mutation within a proto-oncogene,An increase in the amount of a certain protein.A chromosomal translocation with the increased expressions, it transforms to further more potent genes ultimately leading to cancer. The cell growth and differentiation are generally stimulated by the proteins or steroids. The Journal of Integrative Oncology is an academic journal – hosted by OMICS publishing GROUP – a pioneer in open access publishing–and is listed among the top 10 journals in Oncogene. Each year research scientists have noticed a rise in the number of congresses being held in this field.
National symposiums and Workshops provide a dedicated forum for the advancement, implementation and exchange of information .Around 10 National symposiums and Workshops are going to be held across the globe which includes “Summer Symposium 2010. Oncogenic Kras”, “Oncogenes and Angiogenesis”, “15th International Symposium on EBV “ and “The 24th Beckman Symposium”
The societies working on Oncogenic’s are BC Cancer Research Centre , Edinburgh Cancer Research UK Centre, Manchester Cancer Research Centre.
The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.
This page will be updated regularly.
This page was last updated on August 4, 2020